Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01104246 · ClinicalTrials.gov registry record · Phase 1
Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men
A Phase 1 study, sponsored by Watson Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT01104246 is a Phase 1 study that has completed, run by Watson Pharmaceuticals. The registered enrollment target is 40 participants.
The verdict
NCT01104246, a Phase 1 study, has completed, sponsored by Watson Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The study will evaluate the pharmacokinetics of testosterone transdermal systems at steady-state in hypogonadal men.
Interventions
- DRUG Testerone Transdermal System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-04 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01104246
The ClinicalTrials.gov registry entry for NCT01104246 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Watson Pharmaceuticals, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Testerone Transdermal System is the first listed.
NCT01104246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01104246 about?
NCT01104246 is a clinical study titled "Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men". The study will evaluate the pharmacokinetics of testosterone transdermal systems at steady-state in hypogonadal men.
What is the current status of trial NCT01104246?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2010-04. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01104246?
The interventions under investigation include: Testerone Transdermal System (DRUG).
Who is sponsoring clinical trial NCT01104246?
This trial is sponsored by Watson Pharmaceuticals, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.